Literature DB >> 12100125

Non-endocrine late complications of bone marrow transplantation in childhood: part I.

Alison D Leiper1.   

Abstract

Mesh：

Year:  2002        PMID： 12100125     DOI： 10.1046/j.1365-2141.2002.03470.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  17 in total

Review 1.  Anxiety, depression, and mental health-related quality of life in survivors of pediatric allogeneic hematopoietic stem cell transplantation: a systematic review.

Authors:  Tal Schechter; Jason D Pole; Giancarlo Di Giuseppe; Nirav Thacker
Journal:  Bone Marrow Transplant       Date:  2020-01-24       Impact factor: 5.483

Review 2.  Haemopoietic stem cell transplantation for genetic disorders.

Authors:  C G Steward; A Jarisch
Journal:  Arch Dis Child       Date:  2005-12       Impact factor: 3.791

3.  Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).

Authors:  Can-Lan Sun; Liton Francisco; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

4.  Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.

Authors:  K Scott Baker; Kirsten K Ness; Julia Steinberger; Andrea Carter; Liton Francisco; Linda J Burns; Charles Sklar; Stephen Forman; Daniel Weisdorf; James G Gurney; Smita Bhatia
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

5.  Late effects and quality of life of childhood cancer survivors: part 1. Impact of stem cell transplantation.

Authors:  Yasushi Ishida; Misato Honda; Shuichi Ozono; Jun Okamura; Keiko Asami; Naoko Maeda; Naoko Sakamoto; Hiroko Inada; Tsuyako Iwai; Kiyoko Kamibeppu; Naoko Kakee; Keizo Horibe
Journal:  Int J Hematol       Date:  2010-05-15       Impact factor: 2.490

6.  Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up.

Authors:  M Wilhelmsson; A Vatanen; B Borgström; B Gustafsson; M Taskinen; U M Saarinen-Pihkala; J Winiarski; K Jahnukainen
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

7.  Ozone-Oxidative Preconditioning Prevents Doxorubicin-induced Cardiotoxicity in Sprague-Dawley Rats.

Authors:  Livan Delgado-Roche; Yanet Hernández-Matos; Emilio A Medina; Dalia Á Morejón; Maité R González; Gregorio Martínez-Sánchez
Journal:  Sultan Qaboos Univ Med J       Date:  2014-07-24

8.  Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.

Authors:  D Bresters; A Lawitschka; C Cugno; U Pötschger; A Dalissier; G Michel; K Vettenranta; M Sundin; A Al-Seraihy; M Faraci; P Sedlacek; A B Versluys; A Jenkins; P Lutz; B Gibson; A Leiper; M A Diaz; P J Shaw; R Skinner; T A O'Brien; N Salooja; P Bader; C Peters
Journal:  Bone Marrow Transplant       Date:  2016-06-27       Impact factor: 5.483

9.  Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes.

Authors:  Eugene A Konorev; Sravan Vanamala; Balaraman Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2008-09-20       Impact factor: 7.376

10.  Nail dystrophy, edema, and eosinophilia: harbingers of severe chronic GVHD of the skin in children.

Authors:  J T Huang; C N Duncan; D Boyer; H Khosravi; L E Lehmann; A Saavedra
Journal:  Bone Marrow Transplant       Date:  2014-09-22       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.